Abstract
Background and Objectives:
Molecular typing methods are important and useful tools to assess the transmission, diversity of strains and differentiation between new infections and relapses which can effectively help in controlling infections. The aim of this study was to evaluate the molecular typing methods which have been used in Iran. By evaluating the results and discriminatory power of each method, we can assign appropriate weight to each technique and ultimately offer a common strategy for future epidemiological studies.
Method:
We searched several databases to identify studies addressing Mycobacterium tuberculosis molecular epidemiology in Iran. Hunter-Gaston discrimination index (HGDI) was used to evaluate the discriminatory power in each method. Relevant articles were selected and analyzed; HGDI index was calculated for each technique.
Results:
The most common genotyping methods used in the articles were RFLP, MIRU-VNTR, spoligotyping, PFGE and RAPD-PCR. The most frequently techniques were IS6110-RFLP, MIRU-VNTR and spoligotyping alone or in combination. The highest discrimination power (average HGDI: 0.9916) was obtained by RFLP followed by MIRU-VNTR (average HGDI: 0.9638) and spoligotyping (average HGDI: 0.9041) respectively.
Conclusion:
Combination of MIRU-VNTR with spoligotyping can be recommended for large-scale genotyping in Iran. It seems appropriate to consider spoligotyping as the first technique for screening followed by other techniques with higher discrimination power such as MIRU-VNTR or IS6110-RFLP.
Keywords: Mycobacterium tuberculosis, Molecular epidemiology, Genotyping, HGDI, RFLP, MIRU-VNTR, Spoligotyping
INTRODUCTION
Mycobacterium tuberculosis is one of the most important pathogens in the world (1). The emergence of Multi-Drug Resistant strains (MDR) and co-infection with the HIV virus is considered one of the biggest health problems (2). According to the World Health Organization reports, in 2013, nine million people developed TB out of which 1.5 million lost their lives due to this disease. The WHO report in 2014 showed the number of people with TB was on the rise; the report also emphasized that the number of MDR-TB had increased in the past two decades (3). As Iran is in close proximity to high-prevalence countries, prevention of the spread of tuberculosis cases particularly MDR-TB is one of the priorities of the country (4).
The use of methods that can identify and track TB transmission is helpful in controlling the disease. Planning for TB control needs an identification of the sources of infection and the spread of disease. With the development of molecular epidemiology in recent years, the possibility of studying the epidemiology of infectious diseases has increased significantly. For understanding the path for disease transmission, molecular epidemiology studies are essential in order to prevent the spread of disease (5). Therefore, genotyping techniques are powerful tools for identifying the outbreak, contact tracing, and studying the diversity of strains. Also, increasing knowledge in this area may be considered as an effective way to prevent transmission (6).
Many different molecular epidemiology techniques have been proposed for identifying the genetic relationship between different strains of Mycobacterium tuberculosis and bovis (6–8). M. tuberculosis has very conserved genome; as little nucleotide diversity was reported in their genome, this organism is genetically monomorphic (9). Although genome of M. tuberculosis complex is highly conserved in comparison to other bacterial pathogens, some variation does exist (10, 11).
Today, there are various methods for genotyping of M. tuberculosis which is called fingerprinting techniques. Genotyping methods can be briefly classified as follows:
Sequence-based standard methods such as whole genome sequencing.
- Non Sequence-based methods: these methods are generally classified into two categories:
- Non-amplified methods (gel- based techniques) such as Pulsed Field Gel Electrophoresis (PFGE) and Restriction Fragment Length Polymorphism (RFLP)
- Amplified methods (PCR-based genotyping methods) such as spoligotyping, Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat (MIRU- VNTR), Random Amplified Polymorphic DNA Polymerase chain reaction (RAPD-PCR), Repetitive element palindromic PCR (REP-PCR).
Often these techniques are based on the repetitive sequences (6). There are two types of repetitive units, interspersed repeats (IR) (Direct Repeats [DR], insertion sequence-like repeats [IS]) and tandem repeats (TR) (variable-number tandem repeats [VNTR]) (10, 11). Each method has some advantages and disadvantages (6, 9, 12, 13).
OBJECTIVES
The aim of this study was to evaluate the molecular typing methods used in Iran. By evaluating discriminatory power of each method and comparing the results, we can assign appropriate weight to each technique and propose a common strategy for future epidemiological studies. Hunter-Gaston Discrimination Index (HGDI) was used to evaluate the Discriminatory Power for each method (12).
METHODS
Search strategy.
We searched several databases such as PubMed, Web of Science, Scopus, Iran Medex, Google Scholar, and Scientific Information Database (SID) to identify studies addressing M. tuberculosis molecular epidemiology in Iran. Keywords that were selected for this research were: molecular epidemiology, tuberculosis and Iran. Moreover, to search for articles that were published in Persian, the corresponding Persian keywords were used.
Having the search conducted, 25 articles in English and 9 Persian articles were shortlisted; while others were excluded from the study due to lack of relevance or unavailability. Papers either contained HGDI index or the information necessary to calculate this index; we reviewed the selected articles and used the already existing indexes or calculated the index based on the data extracted from the articles. The indexes were calculated according to the following equation:
Where N is the total number of strains in the sample population, s is the total number of types described, and nj is the number of strains belonging to the jth type. D can take any figure between 0–1 while the lowest and largest discriminatory power indexes are represented by 0 and 1, respectively. Assessing and determining the discriminatory power of the molecular epidemiology is important because based on the results of this study, a more powerful tool can be selected for the genotyping research.
RESULTS
After evaluating all articles, 34 relevant articles (Published from 2000 to 2014) were selected for analysis (Diagram 1). All 34 articles contained information necessary to calculate HGDI index. As presented in Diagram 1, molecular typing techniques frequently used in Iran were RFLP (IS6110, PGRS and DR), MIRU-VNTR, spoligotyping, PFGE and RAPDPCR. The majority of the methods used in the literature were spoligotyping with 18 studies followed by IS6110-RFLP and MIRU-VNTR with 9 and 7 cases respectively.
Diagram 1.
Number of methods and articles reviewed in the study
Diagram 2.
Number of methods used in the articles reviewed here
Our search demonstrated that IS6110 - RFLP had the highest HGID (an average HGID of 0.9897), followed by Polymorphic GC-rich Repetitive Sequences (PGRS) - RFLP (average HGID: 0.9904) and MIRU-VNTR (average HGID: 0.9638) and spoligotyping (average HGID: 0.9433) and the lowest discrimination power (average HGDI: 0.6974) was obtained for PFGE. In most studies, a combination of two or three methods was used. The combination of two or more methods showed higher HGDI values than single method. HGDI values in each method were almost close to 100%. Results are presented in Table 1.
Table 1.
Comparative analysis of genotyping methods of Mycobacterium tuberculosis published by Iranian scientists.
| Reference | First author | Enrollment time | Provinces and research centers | Methods used (single, dual) | Number of isolates | Non-clustered isolates | No. of clusters | No. of clustered isolates | HGDI | Average HGDI |
|---|---|---|---|---|---|---|---|---|---|---|
| (15) | P. Ravan | ND | 5 provinces of Iran | IS6110-RFLP | 258 | 197 | 30 | 61 | 0.9990 | |
| (34) | B. Nasiri | 2008–2009 | Tehran | IS6110-RFLP | 291 | 231 | 25 | 60 | 0.9987 | |
| (35) | M. Doroudchi | 1995–1996 | Fars | IS6110-RFLP | 62 | 50 | 6 | 12 | 0.9968 | |
| (19) | Asgharzadeh M, | 2004–2005 | North west of Iran | IS6110-RFLP | 154 | 107 | 16 | 47 | 0.9939 | |
| (36) | Farnia, P. | 2001 | Tehran | IS6110-RFLP | 129 | 73 | 94 | 56 | 0.9927 | 0.9897 |
| (37) | Asgharzadeh M, | 2002–2003 | East Azerbaijan | IS6110-RFLP | 105 | 70 | 11 | 35 | 0.9897 | |
| (38) | Farazi, A. | 2011–2012 | central province | IS6110-RFLP | 95 | 20 | 28 | 75 | 0.9827 | |
| (39) | Farnia, P. | 2006 – 2007 | NRITLD | IS6110-RFLP | 258 | 193 | 29 | 65 | 0.9793 | |
| (40) | NedaAlikosarzadeh | 2010–2011 | Pasteur Institute | IS6110-RFLP | 100 | 19 | 25 | 81 | 0.9751 | |
| (16) | Rafiee, B. | 2010–2011 | central province | PGRS(PVU II)-RFLP | 57 | 44 | 6 | 50 | 0.9949 | |
| (16) | Rafiee, B. | 2010–2011 | central province | PGRS(AIU I)-RFLP | 57 | 37 | 8 | 45 | 0.9918 | 0.9904 |
| (38) | Farazi, A. | 2011–2012 | central province | PGRS-RFLP | 95 | 22 | 28 | 73 | 0.9847 | |
| (38) | Farazi, A. | 2011–2012 | central province | DR | 95 | 17 | 28 | 78 | 0.9807 | 0.9807 |
| (19) | Asgharzadeh M, | 2004–2005 | Northwest of Iran | IS6110-RFLP + MIRU(12 loci) | 154 | 122 | 13 | 32 | 0.9974 | |
| (19) | Asgharzadeh M, | 2004–2005 | Northwest of Iran | IS6110-RFLP + ETR | 154 | 121 | 14 | 33 | 0.9979 | 0.9980 |
| (19) | Asgharzadeh M, | 2004 – 2005 | Northwest of Iran | IS6110-RFLP + MIRU-ETR(15 loci) | 154 | 127 | 13 | 27 | 0.9987 | |
| (19) | Asgharzadeh M, | 2004–2005 | Northwest of Iran | ETR | 154 | 4 | 17 | 150 | 0.8959 | 0.8959 |
| (24) | Ahmadi, M | 2009–2010 | central province | MIRU-ETR(12 loci) | 53 | 40 | 5 | 13 | 0.9869 | |
| (19) | Asgharzadeh M, | 2004–2005 | Northwest of Iran | MIRU-ETR(15 loci) | 154 | 103 | 22 | 51 | 0.9966 | |
| (2) | Zamani, S. | 2010 | 3 provinces of Iran | MIRU(15 loci) | 121 | 46 | 20 | 75 | 0.9724 | 0.9845 |
| (19) | Asgharzadeh M, | 2004–2005 | Northwest of Iran | MIRU(12 loci) | 154 | 95 | 21 | 59 | 0.9932 | |
| (23) | Asgharzadeh M, | 2002–2003 | East Azerbaijan | MIRU(12 loci) | 127 | 72 | 21 | 55 | 0.9932 | |
| (41) | Vatani, S. | 2008–2010 | Khuzestan | MIRU(12 loci) | 61 | 37 | 11 | 24 | 0.9816 | 0.9510 |
| (42) | Jafarian, M | 2009 | Tehran | MIRU(12 loci) | 60 | 23 | 10 | 37 | 0.9745 | |
| (20) | Jafarian, M | 2006–2007 | Tehran | MIRU(12 loci) | 140 | 0 | 9 | 140 | 0.8126 | |
| (42) | Jafarian, M | 2009 | Tehran | MIRU(12 loci) + spoligotyping | 60 | 9 | 11 | 51 | 0.9468 | 0.9468 |
| (36) | Farnia, P. | 2001 | Tehran | Spoligotyping | 129 | 33 | 14 | 96 | 0.9917 | |
| (43) | Ramazanzadeh, R. | 2003–2004 | NRITLD | Spoligotyping | 195 | 101 | 25 | 94 | 0.9849 | |
| (44) | Rohani, M. | 2004 – 2005 | Mashhad | Spoligotyping | 113 | 44 | 17 | 69 | 0.9688 | |
| (45) | Haeili, M | 2010–2012 | 5 provinces of Iran | Spoligotyping | 291 | 40 | 35 | 251 | 0.9518 | |
| (35) | Doroudchi, M. | 1995–1996 | Fars | Spoligotyping | 97 | 27 | 7 | 70 | 0.9467 | |
| (46) | Velayati, A. A. | 2000 – 2005 | NRITLD | Spoligotyping | 1385 | 63 | 71 | 1679 | o.9281 | 0.9433 |
| (47) | Merza, Muayad A. | 2000–2005 | NRITLD | Spoligotyping | 1742 | 63 | 71 | 1679 | 0.9232 | |
| (48) | Torkaman, M. R. | 2009 – 2010 | NRITLD | Spoligotyping | 102 | 25 | 10 | 77 | 0.911 | |
| (49) | Farnia, P. | 2000 – 2005 | NRITLD | Spoligotyping | 263 | 10 | 17 | 253 | 0.9066 | |
| (50) | Mozafari, M. | 2010–2011 | Tehran | Spoligotyping | 212 | 27 | 17 | 185 | 0.9051 | |
| (51) | Mozafari, M. | 2010–2011 | 24 provinces of Iran | Spoligotyping (*) | 1242 | 77 | 59 | 1165 | 0.8901 | |
| (39) | Farnia, P. | 2006 – 2007 | NRITLD | Spoligotyping (*) | 258 | 27 | 9 | 231 | 0.882 | |
| (52) | Mozafari, M. | No Data | NRITLD | Spoligotyping (*) | 105 | 14 | 12 | 91 | 0.8619 | |
| (53) | Amirmozafari, N | 2004–2005 | NRITLD | Spoligotyping (*) | 220 | 39 | 9 | 181 | 0.8424 | Incomplete |
| (54) | DerakhshaniNezhad Z | 2010–2011 | NRITLD | Spoligotyping (*) | 106 | 3 | 9 | 103 | 0.8122 | data |
| (55) | Sharifipour, E | 2011–2012 | Tehran | Spoligotyping (*) | 190 | 52 | 4 | 138 | 0.8089 | |
| (56) | Taj, aldinE | 2007–2008 | Tehran | Spoligotyping (*) | 238 | 0 | 9 | 238 | 0.8076 | |
| (57) | Hashemi, A. | 2006–2008 | Khuzestan | RAPD PCR | 96 | 16 | 15 | 80 | 0.9186 | 0.9413 |
| (58) | Haghighi, M.A | 1996–1998 | Fars | RAPD-PCR | 44 | 15 | 13 | 29 | 0.964 | |
| (31) | Khosravi, A. D. | 2008–2010 | Khuzestan | PFGE ( Dra1,Xba1) | 60 | 19 | 17 | 41 | 0.979 | 0.6974 |
| (30) | Poyeede, M. | 2010–2011 | Pasteur Institute | PFGE(Xba1) | 100 | 0 | 2 | 100 | 0.4159 |
NRITLD: The National Research Institute of Tuberculosis and Lung Diseases (Tehran, Iran)
DISCUSSION
Different typing methods demonstrated a wide range of discrimination power. HGDI values were from 0.4159 up to 0.9990. We used HGDI index to assess the discriminatory power of molecular typing techniques. Each genotyping method has a different value for this index in different articles depending on various parameters such as number and distribution of samples (14). A minimum of HGDI value more than 0.90 is desired for a test to distinguish among related organisms (12). The analysis of HGDI values for each typing method in this study showed that IS6110-RFLP had the highest HGDI value of 0.9990 and the lowest HGDI belonged to PFGE with an average value of 0.4159. The analysis of HGDI values for IS6110-RFLP showed an average of 0.9897 ranging from 0.9990 to 0.9751. The highest value was achieved by the analysis of isolates obtained from five provinces of Iran (15), and the lowest of them was obtained from Tehran Province (16). The major advantage of this method is the higher discriminatory power it provides but it suffers from the long time required and technical difficulties in conducting. Furthermore, IS6110-RFLP has low discriminatory power in strains with fewer than 6 copy number of IS6110 sequences (13, 17).
PGRS fingerprinting in terms of technical and other conditions were similar to IS6110-RFLP. HGDI values are also similar to IS6110-RFLP. Also, it has been proven that PGRS fingerprinting is useful for differentiating M. tuberculosis strains with less than six copies of IS6110 that cannot be successfully examined by IS6110 fingerprinting (1, 18).
In the present study, MIRU-VNTR showed high HGDI average value of HGDI = 0.9638 after RFLP. In this study, maximum HGDI value for MIRU-VNTR was 0.9966 (19) and the lowest was 0.8126 (20). The discriminatory power of MIRU-VNTR technique depends on the number and type of selected loci, in addition to the number and distribution of samples (21). The highest HGDI value for MIRU-VNTR in Iran has been reported by Asgharzadeh and colleagues who used a 15-locus MIRU-VNTR typing method (19). Barlow et al. believe that the use of 12 appropriate loci in MIRU-VNTR will provide high discriminatory power (22). Asgharzadeh et al. (23) and Ahmadi et al. (24) who used the 12 loci MIRU-VNTR, obtained HGDI indexes 0.9932 and 0.9869, respectively. In both articles, ETR and MIRU loci have been used. It seems that little difference in the discriminatory power of these two studies was related to sample size (127 samples versus 53 samples).
The advantages of MIRU-VNTR are high discriminatory power, high reproducibility (25) and the ability to create a numeric code for each isolate which facilitate its tracing in the database as well as ease and cost-effectiveness. Due to these advantages, this method has become a favorite method for epidemiological and phylogenetic researchers. Thus, Supply et al. proposed a 15-locus system as a new standard for routine epidemiological discrimination of M. tuberculosis isolates and a 24-locus system as a high-resolution tool for phylogenetic studies (21). The simultaneous use of two techniques enhances the discriminatory power. In a relevant study, Asgharzadeh et al. showed that the combination of IS6110 and MIRU-VNTR had the greater discriminatory power than either method alone (19). In another study, Barlow et al. obtained similar findings (22).
The third most widely used technique in the articles we reviewed was spoligotyping, and the average HGDI value for spoligotyping was 0.9041, the highest HGDI average value was 0.9917 and the lowest was 0.8076. However, because the results of some papers were incomplete, or they were identified only up to the super family level, the value of HGDI was lower in these articles (marked with * in Table 1). Therefore, considering only the articles with full data on the calculations, the average HGDI for this technique will be 0.9433.
As observed, the discriminatory power of spoligotyping was less than the two other techniques. The reason for the lower discriminatory power of this method is that it targets only a single genetic locus, included less than 0.1% of the M. tuberculosis complex genome (26). An important advantage of spoligotyping is its sensitivity which can be performed by 10 fg of chromosomal DNA, equivalent to DNA from 2–3 bacterial cells (27), so that the method can be directly performed on clinical samples, without the need for prior culture. Moreover, spoligotyping has proven to be practical for typing on nonviable samples such as paraffin-embedded tissue sections or Ziehl-Neelsen stained slides (28, 29).
Other techniques that we encountered to be used in the articles were RAPD-PCR and PFGE. As observed, their discrimination powers were less than aforementioned techniques. The lowest discrimination power was represented by PFGE (average HGDI= 0.6974). In this review, the discrimination power of PFGE was low because in one manuscript, Poyide et al. used only one restriction enzyme (Xba1) and obtained extremely low discrimination power (HGDI value = 0.4159) (30). Although in another study conducted by Khosravi et al., they used two restriction enzymes (Dra1 and Xba1) and the discrimination power was higher (HGDI value = 0.9790) (31).
In general, each typing system has its own advantages and disadvantages, and it is difficult to decide clearly which of them is superior to others. But an ideal molecular typing method must comply with the needs of researchers in terms of performance feasibility as well as analytical standards (26). The performance parameters included technical simplicity or ease of implementation, repeatability, robustness, time and cost-effectiveness. Another special advantage of the method was that it can be standardized and the results would be easily interpretable. The results should simply be comparable with the results of other laboratories as well as global databases. Another attractive advantage of a technique is its capability to be performed directly on clinical samples (26).
Analytical parameters include the level of genetic differentiation and stability of markers. A general rule is that the higher discriminatory power of the method, the more reliable the results obtained. It has been confirmed that discriminatory power of a molecular marker relates directly to its stability. Half-life of IS6110-RFLP profile is much shorter than the profile of spoligotyping (about 3 to 8 years in RFLP compared to spoligotyping with more than 50 years). The half-life of MIRU-VNTR is slightly longer than RFLP profiles and shorter than spoligotyping. The half-life of a desirable molecular marker should be short enough to separate unrelated samples from each other and on the other hand be long enough to be able to find the relationship between epidemiological samples (26).
Selecting a genotyping method, in compliance with good discriminatory power, also depends on the type of research. A technique with high discriminatory power with short half-life of genetic pattern (e.g. RFLP and MIRU-VNTR techniques) is more useful to distinguish reactivation from reinfection, while a method with a long half-life of genetic pattern (such as spoligotyping) is more useful for global strain tracking and evolutionary studies. Therefore, it is better to perform typing with a combination of these techniques.
Gold standard for M. tuberculosis genotyping was IS6110-RFLP, but it needs to change to MIRU-VNTR technique because of its similar discriminatory power in addition to feasibility, time and cost-effectiveness as well as the interpretation of results. More importantly, the PCR-based typing methods require fewer bacteria and can be performed in a shorter period of time. Thus, many researchers have focused on the MIRU-VNTR method as a standard technique.
Spoligotyping method has attracted the attention of researchers because of simplicity and cost-effectiveness in addition to the advantage that the results are expressed as positive or negative, according to the presence or absence of the spacers (digital format) (32). However spoligotyping will not be sufficient to be used alone in the epidemiological studies. Therefore, spoligotyping is recommended to be used as a first-line screening test, followed by techniques with higher discriminatory power such as MIRU-VNTR or IS6110-RFLP (33). Also, it should be emphasized that the present study was limited to techniques reported in Iran. Therefore, the number of articles relating to some methods was too low. There are other genotyping techniques used by researchers around the world which were not included in this article.
CONCLUSION
According to the present study, combination of MIRU-VNTR with spoligotyping can be recommended for large-scale genotyping in Iran. It seems appropriate to consider spoligotyping as the first techniques for screening followed by other techniques with higher discrimination abilities such as MIRU-VNTR or IS6110-RFLP.
ACKNOWLEDGEMENT
The authors would thank the research team who helped in completing this project.
REFERENCES
- 1. Soleimanpour S, Hamedi Asl D, Tadayon K, Farazi AA, Keshavarz R, Soleymani K, et al. Extensive genetic diversity among clinical isolates of Mycobacterium tuberculosis in Central Province of Iran. Tuberc Res Treat 2014; 195287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Zamani S, Aflaki M, Fooladi AAI, Darban-Sarokhalil D, Bameri Z, Khazaee S, et al. MIRU-VNTR analysis of the Mycobacterium tuberculosis isolates from three provinces of Iran. Scand J Infect Dis 2013; 45: 124– 130 . [DOI] [PubMed] [Google Scholar]
- 3. WHO Global tuberculosis report 2015. World Health Organization; Geneva [Switzerland] 2015. [Google Scholar]
- 4. Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Rezadehbashi M, Zamani S. Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis. Am J Infect Control 2014;42: 1212– 1218 . [DOI] [PubMed] [Google Scholar]
- 5. Asgharzadeh M, Samadi Kafil H, Pourostadi M. Source case identification and control of tuberculosis by molecular epidemiology. J Mazandaran Univ Med Sci (Persian) 2014; 24 (115): 181– 92. [Google Scholar]
- 6. Moström P, Gordon M, Sola C, Ridell M, Rastogi N. Methods used in the molecular epidemiology of tuberculosis. Clin Microbiol Infect 2002; 8: 694– 704 . [DOI] [PubMed] [Google Scholar]
- 7. Tadayon K, Forbes K, Soleimani D, Pajoohi RA, Marhmati B, Javidi J, et al. A review of the contemporary knowledge of bovine tuberculosis and government policy in Iran. Vet Microbiol 2011; 151: 192– 199 . [DOI] [PubMed] [Google Scholar]
- 8. Tadayon K, Mosavari N, Feizabadi MM. An epidemiological perspective on bovine tuberculosis spotlighting facts and dilemmas in Iran, a historically zebu-dominant farming country. Iran J Microbiol 2013; 5: 1– 13 . [PMC free article] [PubMed] [Google Scholar]
- 9. Comas I, Homolka S, Niemann S, Gagneux S. Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS One 2009; 4(11):e7815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006;19: 658– 685 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Schurch AC, van Soolingen D. DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing. Infect Genet Evol 2012; 12: 602– 609 . [DOI] [PubMed] [Google Scholar]
- 12. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson’s index of diversity. J Clin Microbiol 1988; 26: 2465– 2466 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Rozo-Anaya JC, Ribon W. Molecular tools for Mycobacterium tuberculosis genotyping. Rev Salud Publica (Bogota) 2010; 12: 510– 521 . [PubMed] [Google Scholar]
- 14. Asgharzadeh M, Samadi Kafil H. Current trends in molecular epidemiology studies of Mycobacterium tuberculosis. Biotechnol Mol Bio. Rev 2007; 2:108–115. [Google Scholar]
- 15. Ravan P, Farnia P, Amirmozafari N, Taghavi K, Ahmadi M, Masjedi MR, et al. Molecular epidemiology analysis of TB in five regional states of Iran. Tanaffos 2013; 12: 26– 30 . [PMC free article] [PubMed] [Google Scholar]
- 16. Rafiee B, Mosavari N, Farazi AA, Nazari R, Keshavarz R, Tadayon K. DNA fingerprinting of Mycobacterium tuberculosis isolates of pulmonary tuberculosis patients in Markazi province by PGRS-RFLP method. AMUJ 2012; 15(6):35–44 (In Persian). [Google Scholar]
- 17. Rafiee B, Mosavari N, Ghani S, Sadeghi D, Keshavarz R, Tadayon K. Molecular Characterization of Mycobacterium bovis Isolates with High Copy Number of IS6110 by Restriction Fragment Length Polymorphism. ZJRMS 2014:70–72. (In Persian) [Google Scholar]
- 18. Yang ZH, Ijaz K, Bates JH, Eisenach KD, Cave MD. Spoligotyping and polymorphic GC-rich repetitive sequence fingerprinting of Mycobacterium tuberculosis strains having few copies of IS6110. J Clin Microbiol 2000; 38: 3572– 3576 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Asgharzadeh M, Kafil HS, Roudsary AA, Hanifi GR. Tuberculosis transmission in Northwest of Iran: using MIRU-VNTR, ETR-VNTR and IS6110-RFLP methods. Infect Genet Evol 2011;11: 124– 131 . [DOI] [PubMed] [Google Scholar]
- 20. Jafarian M, Farnia P, Mozafari M, Ahmadi M, Masjiedi M, Velayati A. Comparison of the genetic convergence degree of Mycobacterium tuberculosis (TB) strains isolated from patients infected with TB by MIRU-VNTR technique. ZUMS Journal 2011; 19:25–36. (In Persian) [Google Scholar]
- 21. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44:4498–4510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Barlow RE, Gascoyne-Binzi DM, Gillespie SH, Dickens A, Qamer S, Hawkey PM. Comparison of variable number tandem repeat and IS6110-restriction fragment length polymorphism analyses for discrimination of high- and low-copy-number IS6110 Mycobacterium tuberculosis isolates. J Clin Microbiol 2001; 39: 2453– 2457 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Asgharzadeh M, Khakpour M, Salehi TZ, HS K. Use of miru-vntr typing to study Mycobacterium tuberculosis isolates from East Azarbaijan province of Iran. PJBS 2007; 10: 3769– 3777 . [DOI] [PubMed] [Google Scholar]
- 24. Ahmadi M, Tadayon K, Mosavari N, Farazi A, Arjomandzadegan M, Keshavarz R, et al. Mycobacterium tuberculosis genotyping by MIRU-VNTR method. J Gorgan Uni Med Sci 2015; 17 (1): 97– 106. [Google Scholar]
- 25. Kremer K, Arnold C, Cataldi A, Gutierrez MC, Haas WH, Panaiotov S, et al. Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains. J Clin Microbiol 2005; 43: 5628– 5638 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Jagielski T, van Ingen J, Rastogi N, Dziadek J, Mazur PK, Bielecki J. Current methods in the molecular typing of Mycobacterium tuberculosis and other Mycobacteria. BioMed Res Int 2014. ; 2014:645802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Kulkarni S, Sola C, Filliol I, Rastogi N, Kadival G. Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India. Res Microbiol 2005; 156: 588– 596 . [DOI] [PubMed] [Google Scholar]
- 28. Driscoll JR, McGarry MA, Taber HW. DNA typing of a nonviable culture of Mycobacterium tuberculosis in a homeless shelter outbreak. J Clin Microbiol 1999; 37: 274– 275 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Van der Zanden A, Hoentjen A, Heilmann F, Weltevreden E, Schouls L, Van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis complex in paraffin wax embedded tissues and in stained microscopic preparations. Molecular Pathology 1998; 51 (4): 209– 214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Poyeede Mohammad, Jabarzade Esmaeil, Masoumi Morteza, Ranjbar Reza, Ahmadi Zeynab, Saifi M. Pulsed Field Gel Electrophoresis and Genetic Diversity in Mycobacterium tuberculosis. Iran J Clin Infect Dis 2013; 18:21–26. (In Persian) [Google Scholar]
- 31. Khosravi AD, Vatani S, Feizabadi MM, Abasi Montazeri E, Jolodar A. Application of Pulsed Field Gel Electrophoresis for study of genetic diversity in Mycobacterium tuberculosis strains isolated from tuberculosis patients. Jundishapur J Microbiol 2014; 7(5):e9963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martin C, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999; 37: 2607– 2618 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Goguet de la Salmoniere YO, Li HM, Torrea G, Bunschoten A, van Embden J, Gicquel B. Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Microbiol 1997; 35:2210–2214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Nasiri B. Evaluation and molecular comparison of Mycobacterium tuberculosis strains isolated from Iranian and Afghan immigrants in Tehran. Iran J Med Microbiol 2014;8:22–27. (In Persian) [Google Scholar]
- 35. Doroudchi M, Kremer K, Basiri EA, Kadivar MR, Van Soolingen D, Ghaderi AA. IS6110-RFLP and spoligotyping of Mycobacterium tuberculosis isolates in Iran. Scand J Infect Dis 2000; 32: 663– 668 . [DOI] [PubMed] [Google Scholar]
- 36. Farnia P, Mohammadi F, Masjedi MR, Varnerot A, Zarifi AZ, Tabatabee J, et al. Evaluation of tuberculosis transmission in Tehran: using RFLP and spoligotyping methods. J Infect 2004; 49: 94– 101 . [DOI] [PubMed] [Google Scholar]
- 37. Asgharzadeh M, Shahbabian K, Majidi J, Aghazadeh AM, Amini C, Jahantabi AR, et al. IS6110 restriction fragment length polymorphism typing of Mycobacterium tuberculosis isolates from East Azerbaijan Province of Iran. Mem Inst Oswaldo Cruz 2006;101: 517– 521 . [DOI] [PubMed] [Google Scholar]
- 38. Farazi A, Jabbariasl M, Tadayon K, Mossavar N, Keshavarz R, Hoseini Sd, et al. Comparison of the genetic convergence between Mycobacterium strains by three RFLP-based methods in central province of Iran. Iran J Basic Med Sci 2014; 17: 401– 405 . [PMC free article] [PubMed] [Google Scholar]
- 39. Farnia P, Masjedi MR, Varahram M, Mirsaeidi M, Ahmadi M, Khazampour M, et al. The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping. BMC Infect Dis 2008; 8: 109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Alikosarzadeh Neda, Jabbarzadeh Esmail, Safarpoor Elham, Bahrmand Ahmad Reza, Masoumi Morteza, Karimi Ali, et al. Molecular typing of Mycobacterium tuberculosis by IS6110-RFLP Method. Iran J Clin Infect Dis 2013; 18:29–36. (In Persian) [Google Scholar]
- 41. Vatani S, Khosravi A, Feizabadi M, Jolodar A. Study of genetic diversity in Mycobacterium tuberculosis by using mycobacterial interspersed repetitive unit: Variable number tandem repeat typing in Khuzestan Province, Iran. Afr J Microbiol Res 2011; 5: 1549– 1556 . [Google Scholar]
- 42. Jafarian M, Aghali-Merza M, Farnia P, Ahmadi M, Masjedi MR, Velayati AA. Synchronous comparison of Mycobacterium tuberculosis epidemiology strains by “MIRU-VNTR” and “MIRU-VNTR and spoligotyping” technique. AJMB 2010;2: 145– 152 . [PMC free article] [PubMed] [Google Scholar]
- 43. Ramazanzadeh R, Farnia P, Amirmozafari N, Ghazi F, Ghadertotonchi Z, Kamran J, et al. Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients. Chemotherapy 2006; 52: 316– 320 . [DOI] [PubMed] [Google Scholar]
- 44. Rohani M, Farnia P, Nasab MN, Moniri R, Torfeh M, Amiri MM. Beijing genotype and other predominant Mycobacterium tuberculosis spoligotypes observed in Mashhad city, Iran. Indian J Med Microbiol 2009; 27: 306– 310 . [DOI] [PubMed] [Google Scholar]
- 45. Haeili M, Darban-Sarokhalil D, Fooladi AAI, Javadpour S, Hashemi A, Siavoshi F, et al. Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis isolates from five provinces of Iran. Microbiology Open 2013; 2: 988– 996 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Velayati AA, Farnia P, Mirsaeidi M, Reza Masjedi M. The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and Afghan TB cases. Scand J Infect Dis 2006; 38 (6–7): 463– 468. [DOI] [PubMed] [Google Scholar]
- 47. Merza MA, Farnia P, Salih AM, Masjedi MR, Velayati AA. The most predominant spoligopatterns of Mycobacterium tuberculosis isolates among Iranian, Afghan-immigrant, Pakistani and Turkish tuberculosis patients: a comparative analysis. Chemotherapy 2010; 56: 248– 257 . [DOI] [PubMed] [Google Scholar]
- 48. Torkaman MR, Nasiri MJ, Farnia P, Shahhosseiny MH, Mozafari M, Velayati AA. Estimation of recent transmission of Mycobacterium tuberculosis strains among Iranian and Afghan immigrants: A cluster-based study. J Clin Diagn Res 2014; 8 (9): DC05– DC08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Farnia P, Masjedi MR, Mirsaeidi M, Mohammadi F, Jallaledin G, Vincent V, et al. Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients. J Infect 2006; 53: 331– 336 . [DOI] [PubMed] [Google Scholar]
- 50. Mozafari M, Farnia P, varahram M. Evaluation of spoligotyping pattern of Mycobacterium tuberculosis strains isolated from Tehran province in 90–89. Nafas 2013; 1(1):27–32. (In Persian) [Google Scholar]
- 51. Mozafari M, Farnia P, Afraei M, Derakhshani-Nezhad Z, Masjedi MR, Velayati AA. Molecular diversity of Mycobacterium tuberculosis strains indifferent provinces of Iran. Iran J Microbiol 2013;5: 366– 373 . [PMC free article] [PubMed] [Google Scholar]
- 52. Mozafari M, Farnia P, Jafarian M, Razavi Deligani M, Kazempour M, Masjedi M, et al. Comparison of Mycobacterium tuberculosis Beijing genotype with other Mycobacterium tuberculosis strains Using MIRU-VNTR method. Iran South Med 2012;15 (1): 1– 12. [Google Scholar]
- 53. Amirmozafari N, Ramezanzadeh R, Farnia P, Ghazi F. The frequency of Beijing genotype of Mycobacterium tuberculosis isolated from tuberculosis patients. RJMS 2006; 13: 7– 17 . [Google Scholar]
- 54. Derakhshani Nezhad Z, Sheikolslami F, Farnia P, Deilami Khiabani Z, Ramazanzadeh R, Kazempoor M, et al. Identification and genetic diversity of etambutol resistant strains of Mycobacterium tuberculosis by allelic-specific PCR and spologiotyping. J Ardabil Univ Med Sci 2012; 12(3):248–55. (In Persian) [Google Scholar]
- 55. Sharifipour E, Nasiri M, Farnia P, Mozafari M, Irani S. Evaluation of molecular diversity of Mycobacterium tuberculosis strains by polymorphisms in RD Regions. J Mycobac Dis 2014; 4 (153): 2161– 1068. [Google Scholar]
- 56. Tajadin A, Farnia P, Kargar M, Nawrozi J, Ramazanzadeh R, Ahmadi M, et al. Identification of Mycobacterium tuberculosis beijing genotype using three different molecular methods. Koomesh 2009; 11(1):7–14. (In Persian) [Google Scholar]
- 57. Hashemi A, Shojaei H, Heidarieh P, Aslani MM, Naser AD. Genetic diversity of Iranian clinical isolates of Mycobacterium tuberculosis. New Microbiol 2012;35:61–65. [PubMed] [Google Scholar]
- 58. Haghighi MA, motazedian MH, Al e Yasin F, Ghane Shirazi R. Molecular epidemiology of tuberculosis using RAPD-PCR technique in Fars Province. Iran South Med J 2002; 5: 103– 110 . [Google Scholar]


